Stock, pipeline and biotech catalyst intelligence
Market expectations
Street view at a glance
Analyst expectations are available belowTargets are estimates—not guarantees—and can change after company updates.Wall Street consensus
Strong BuyCoverage varies by companyPrice-target range
—Company profile
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Company profile supplied by Yahoo Finance. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 21, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.